Biomarin Pharmaceutical Shares Fall 15.3% After Positive Trial Data for Rival Ascendis Pharma's Dwarfism Therapy
拜瑪林製藥股價下跌15.3%,競爭對手阿森迪斯製藥的侏儒症療法試驗數據取得積極進展
Biomarin Pharmaceutical Shares Fall 15.3% After Positive Trial Data for Rival Ascendis Pharma's Dwarfism Therapy
拜瑪林製藥股價下跌15.3%,競爭對手阿森迪斯製藥的侏儒症療法試驗數據取得積極進展
譯文內容由第三人軟體翻譯。